This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Pavel Bondarenko - Innovator in Antibody Research
Introduction
Pavel Bondarenko is an accomplished inventor based in Thousand Oaks, CA (US). He currently works at Amgen Inc., a leading biotechnology company. With a focus on antibody research, Bondarenko has made significant contributions to the field, particularly in the development of monoclonal antibodies.
Latest Patent Applications
Pavel Bondarenko has several notable patent applications. One of his latest applications is for "Homogeneous Antibody Populations." This invention is directed to methods of producing an increase in the enrichment and/or recovery of preferred forms of monoclonal antibodies. More specifically, it relates to methods for eliminating disulfide heterogeneity in the hinge region of recombinant IgG2 antibody proteins. Another significant application is for "Agonistic Anti-IL-2RBG Heavy-Chain Antibodies." This disclosure includes heavy-chain antibodies that act as agonists of the dimeric interleukin-2 receptor. It also covers pharmaceutical compositions comprising these antibodies and methods for treating disorders such as cancer, including small cell lung cancer.
Conclusion
Pavel Bondarenko is a dedicated inventor whose work in antibody research is paving the way for advancements in cancer treatment. His innovative approaches and applications reflect his commitment to improving therapeutic options in the biotechnology field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile